In this study, we speculate that EphB4 is the target of PDCD10 in GBM cells and that interfering EphB4 signaling could rescue the phenotype of PDCD10-deficient GBM cells and suppress tumor growth in a mouse model of GBM. Here, EPHB4 is linked to glioblastoma.